NewEdge Advisors’s Veracyte VCYT Stock Holding History

NewEdge Advisors’s Portfolio VCYT Stock Details VCYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-14	Closed	-$590	–	4409
2025 Q4	$590	Buy	+14	New	+$564	﹤0.01%	4036
2025 Q1	–	Sell	-2	Closed	-$79	–	4114
2024 Q4	$79	Hold	2	–	–	﹤0.01%	3797
2024 Q3	$68	Sell	2 -19	-90%	-$535	﹤0.01%	3736
2024 Q2	$455	Sell	21 -122	-85%	-$2.56K	﹤0.01%	3575
2024 Q1	$3.17K	Sell	143 -75	-34%	-$1.83K	﹤0.01%	3279
2023 Q4	$6K	Sell	218 -12,359	-98%	-$298K	﹤0.01%	3063
2023 Q3	$281K	Buy	12,577 +12,567	+125,670%	+$323K	﹤0.01%	1463
2023 Q2	$255	Sell	10 -2,099	-100%	-$50.9K	﹤0.01%	3367
2023 Q1	$47K	Sell	2,109 -500	-19%	-$12.1K	﹤0.01%	2033
2022 Q4	$11.5K	Buy	+2,609	New	+$60.6K	﹤0.01%	2324

Other funds holding VCYT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

NewEdge Advisors's VCYT Position: Q1 2026 in Review

NewEdge Advisors sold out of Veracyte (VCYT) in Q1 2026, closing a stake of 14 shares — an estimated $590 sold.

NewEdge Advisors first reported a position in VCYT in Q4 2022 and held it in 10 quarters. The position peaked at $281K in Q3 2023. 334 funds tracked by Wall St. Rank hold VCYT as of Q1 2026.

NewEdge Advisors reported no remaining Veracyte position as of Q1 2026 after selling out during the quarter.
NewEdge Advisors sold 14 Veracyte shares in Q1 2026, an estimated $590.
NewEdge Advisors first reported a position in Veracyte in Q4 2022 and held it in 10 quarters.
NewEdge Advisors's Veracyte position peaked at $281K in Q3 2023.
334 funds tracked by Wall St. Rank held Veracyte as of Q1 2026.

Based on NewEdge Advisors's 13F filing for Q1 2026, filed 18 May 2026.